White v. The Dow Chemical Company

321 F. App'x 266
CourtCourt of Appeals for the Fourth Circuit
DecidedApril 8, 2009
Docket08-1165
StatusUnpublished
Cited by3 cases

This text of 321 F. App'x 266 (White v. The Dow Chemical Company) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fourth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
White v. The Dow Chemical Company, 321 F. App'x 266 (4th Cir. 2009).

Opinion

Affirmed by unpublished PER CURIAM opinion.

Unpublished opinions are not binding precedent in this circuit.

PER CURIAM:

Melodee White (“Plaintiff’) appeals from the district court’s order granting summary judgment in favor of the Dow Chemical Company and Dow Agrosciences L.L.C. (the “Dow Defendants”). Mrs. White, a citizen of Randolph County, West Virginia, filed this products liability action on March 24, 2005 against the Dow Defendants, E.I. du Pont de Nemours and Company, a foreign corporation (“DuPont”), Arborchem Products Co., a foreign corporation, Monsanto Company, a foreign corporation, Pharmacia Corporation, a foreign corporation, Asplundh Tree Expert Co., a foreign corporation (“Asplundh”), John Doe Herbicide and Chemical Manufacturing Corporation(s), and John Doe Herbi *268 cide and Chemical Distributing Corporation(s), as the Administratrix of the estate of her deceased husband, John W. White, and in her individual capacity and as next friend and guardian of her minor child. She filed this action in the United States District Court for the Southern District of West Virginia pursuant to 28 U.S.C. § 1332, based on the district court’s diversity of citizenship jurisdiction over causes of action between citizens of different states where the amount in controversy exceeds the sum of $75,000, exclusive of interest and costs.

Plaintiff alleged in her complaint that Mr. White died of chronic myelogenous leukemia as a result of the defendants’ negligence, breach of warranty, and strict liability, because he was exposed to their herbicides and/or pesticides while he was employed by Asplundh. Subsequently, Plaintiff amended her complaint naming only the Dow Defendants, DuPont, As-plundh, and the John Doe Herbicide and Chemical Distributing Corporation(s). In the amended complaint, Plaintiff alleged the same causes of action.

The district court granted summary judgment in favor of the Dow Defendants. It held that Plaintiff failed to show that her husband’s injuries were caused by the Dow Defendants’ products. Plaintiff contends that the district court erred in granting the Dow Defendants’ motion for summary judgment because she presented sufficient evidence “from which a reasonable juror could return a verdict in favor of the Plaintiff.” We affirm because we conclude that the evidence presented by Plaintiff in opposition to the Dow Defendants’ motion for summary judgment was insufficient under West Virginia’s products liability law to demonstrate that any of the Dow Defendants’ herbicides caused Mr. White’s illness.

I

A

Plaintiff filed her original complaint against John Doe Herbicide and Chemical Manufacturing Corporation(s); John Doe Herbicide and Chemical Distributing Corporation(s); The Dow Chemical Company, a foreign corporation; Dow Agrosciences, L.L.C., a foreign corporation; E.I. du Pont de Nemours and Company, a foreign corporation; Asplundh Tree Expert Co., a foreign corporation; Arborchem Products Co., a foreign corporation; Monsanto Company, a foreign corporation; Pharma-cia Corporation, a foreign corporation.

She alleged in Count I that each of the defendants except for Asplundh (“The Chemical Defendants”) were liable for their negligence in manufacturing, processing or supplying toxic chemicals that Mr. White used as an Asplundh employee which caused him to develop chronic mye-logenous leukemia, which was the cause of his death.

In Count II, Plaintiff alleged that the Chemical Defendants were liable for breach of warranty for impliedly warranting that their herbicides and pesticides were of good and merchantable quality.

In Count III, Plaintiff alleged that the Chemical Defendants were strictly liable in tort for manufacturing, processing, selling, or supplying chemicals that were in defective condition and were unreasonably dangerous and unfit for their intended use and were deleterious, poisonous and highly harmful to Mr. White; and his exposure to their chemicals caused his death from chronic myelogenous leukemia.

In Count IV, Plaintiff alleged that As-plundh demonstrated a deliberate intention to expose Mr. White to unsafe working conditions by: 1) using herbicides and other chemicals to control unwanted vege *269 tation without warning him of the hazards posed by exposure to herbicides and other toxic chemicals; 2) failing to provide him with adequate safety equipment; and, 3) failing to conduct periodic physical examinations to monitor his blood chemistry and health for signs of changes in his health as the result of such exposure.

In Count V, Plaintiff alleged that each of the Defendants should be ordered to pay damages for causing Mr. White conscious pain and suffering, and mental and emotional distress prior to his death.

In Count VI, Plaintiff alleged that Plaintiff is entitled to wrongful death damages under West Virginia Code § 55-7-6.

B

On August 22, 2005, the Dow Defendants filed a motion pursuant to Rule 12(c) of the Federal Rules of Civil Procedure for a more definite statement “identifying the particular Dow product(s) that Plaintiff contends caused or contributed to the injuries at issue in this lawsuit.” Plaintiff filed a response to the Dow Defendants’ motion on September 8, 2005. She asserted that the allegations in the complaint “provide[d] Dow with sufficient notice under Rule 8(a) of the substance of her cause of action.” The district court denied the Dow Defendants’ motion for a more definite statement on September 16, 2005.

C

The Dow Defendants filed their answer to Plaintiffs complaint on September 26, 2005. Apart from admitting the identity of the parties, the Dow Defendants denied each of the substantive allegations set forth in paragraphs 1 to 40. In response to paragraph 5 of the complaint, the Dow Defendants alleged that they lack “knowledge or information sufficient to form a belief as to the truth of the allegations that John W. White used any products manufactured by The Dow Chemical Company in his workplace, and therefore den[y] the same.”

D

On November 7, 2005, the district court ordered that discovery should proceed in stages. Counsel were directed to “submit to the court an agreed preservation order, which will include provisions to assure preservation and retention of documents and electronic records, including email, which are relevant to this civil action.” The district court ordered that “[fjrom January 3, 2006 through March 17, 2006, counsel shall engage in informal discovery with respect to identifying the substances to which John W. White was exposed prior to his diagnosis.” The district court also ordered that “depositions of individuals with knowledge of the substances to which John W. White was exposed prior to his diagnosis” should be taken during the week of March 13-17, 2006.

At a scheduling conference conducted on May 15, 2006, it was agreed that “[pjrior to the next status conference, counsel for Plaintiff[ ] will interview John White’s former co-workers to determine to which substances, if any, John White was exposed during his employment.”

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
321 F. App'x 266, Counsel Stack Legal Research, https://law.counselstack.com/opinion/white-v-the-dow-chemical-company-ca4-2009.